Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Biological & Pharmaceutical Bulletin|July 5, 2006
Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancerEriko Sato, Ikuko Yano, Mari Jiko, et al.
International Journal of Molecular Medicine|February 9, 2006
Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in ratsKazunori Kusumoto, Akio Ido, Akihiro Moriuchi, et al.
Scientific Reports|June 9, 2016
Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in miceHiroki Yoshimatsu, Atsushi Yonezawa, Kaori Yamanishi, et al.
International Journal of Clinical Oncology|August 19, 2007
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancersMari Jiko, Ikuko Yano, Eriko Sato, et al.
Cancer Chemotherapy and Pharmacology|April 12, 2015
Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injuryKazuhiko Nakano, Hitoshi Ando, Shinsuke Kurokawa, et al.
Human Mutation|November 20, 2010
Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172BGladys Ho, Atsushi Yonezawa, Satohiro Masuda, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 27, 2007
A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa studyAkira Marui, Yasuhiko Tabata, Shinsuke Kojima, et al.
European Journal of Clinical Pharmacology|October 5, 2011
Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantationIkuko Yano, Satohiro Masuda, Hiroto Egawa, et al.
Pharmaceutical Research|August 3, 2013
Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteinsKoji Kato, Haruyuki Mori, Tomoko Kito, et al.
Blood|September 7, 2006
INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activityAsumi Yokota, Shinya Kimura, Satohiro Masuda, et al.
Pageof 19